Royal Philips has acquired BioTelemetry, a Pennsylvania-based healthcare technology company focused on remote cardiac diagnostics and monitoring, for $2.8 billion. BioTelemetry was founded in 2004, when it was known as CardioNet. The company reincorporated as BioTelemetry in 2013 after making a series of acquisitions of its own. Its sales in…
Researchers explored the potential impact of more than 100 risk factors on a person’s risk of sudden cardiac arrest. Some of their findings were what…
New data published in JACC represents another big win for Bayer’s finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD…
The new resource was built to help care teams plan for ascending aorta and aortic root surgeries.
Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson…
Medtronic emphasized that this device should be especially valuable when treating younger patients or those with a small anatomy.
Medtronic emphasized that this device should be especially valuable when treating younger patients or those with a small anatomy.
Duke University Health System has integrated Barostim into its comprehensive heart failure program. For patients with heart failure with reduced ejection fraction (HFrEF), Barostim is…
Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care.
Robotic and traditional mitral valve repair surgeries are mostly associated with similar outcomes when treating elderly patients. In some ways, however, robotic procedures may be…
Michael Reardon, MD, detailed five-year data out of ACC.25 that found Medtronic’s Evolut TAVR platform performs as well as SAVR—and even better in some ways.
